- Strategic partnership in Latin America extended to cover five additional products in therapeutic categories including oncology, pulmonary hypertension, and rare diseases.
- The current market size of the products included in the agreement exceeds USD 100 million.
Adalvo and SteinCares are pleased to announce the extension of their long-term strategic collaboration in Latin America. The companies have recently signed a basket deal for five products to be marketed and distributed in Latin America. The current market size of the products included in the deal exceeds USD 100 million.
These value-added products encompass a diverse range of segments, each catering to specific indications and fulfilling unique patient needs. The portfolio offers a broad list of therapeutic products, some of which include specialty medicine for oncology, pulmonary hypertension, and an exclusive collaboration for an orphan disease.
With this solid partnership, SteinCares and Adalvo continue to strengthen their position in Latin America, providing patients with high-quality and affordable treatment options.
Anil Okay, CEO at Adalvo comments: “We are absolutely thrilled to announce our continued collaboration with SteinCares, which marks a significant milestone in our partnership. This new agreement not only strengthens our efforts to deliver value-added medications worldwide but also places a special emphasis on the Latin American region. We are confident that this enhanced partnership will enable us to make a greater impact on the healthcare landscape and improve access to vital medications across the globe.”
“We are delighted about this increased collaboration with Adalvo, a strategic partnership that will allow us to enhance our product portfolio of innovative and cost-effective medicines. We are deeply committed to improving access to specialty medicines and believe this partnership is an important milestone in our journey to expand access to advanced and affordable healthcare in Latin America. We look forward to continuing to work with Adalvo to make a difference in the lives of millions of patients”, said Mitchell Waserstein, CEO of SteinCares.
The extension of its collaboration with Adalvo is a sign of SteinCares’ strong partnerships with highly innovative pharmaceutical and biotechnology firms. SteinCares is an ideal strategic ally for companies looking to grow their business in Latin America; with a strong focus on specialty healthcare and in-depth knowledge of local market access, regulatory and tendering processes within the region, the company meets the highest quality standards. With operations in over 30 countries across Latin America and the Caribbean, SteinCares effectively maximizes the value of its partners’ assets.
Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 100 countries and for over 110 commercial partners globally. The company’s declared purpose is to make a difference for patients all over the world, driven by our smart collaboration network and commitment to delivering highest quality differentiated products and services to our partners.
With headquarters in Malta, the company has additional offices in more than 16 countries. At Adalvo, we know that our partners like to be bigger, better, and smarter in the dynamic pharmaceutical sector. That’s why our approach is unique, customized to our partners, and is designed to challenge the status quo: together, this helps our partners achieve their business goals.
Adalvo takes pride in its ability to help its partners reach their goals – be those increasing revenues or pushing into new markets. While partners are a high priority, Adalvo is also committed to its purpose and mission to accelerate the growth and development of employees and local communities. Adalvo tirelessly strives for excellence in all of its endeavors, driven by a deep-rooted passion to making a difference for partners.
The company’s purpose driven culture is committed to improving the lives of patients around the world. The dynamic leadership team brings significant experience and industry know-how to Adalvo, which has helped to establish the company as a reliable global partner.
SteinCares is a leader in commercializing and distributing specialty healthcare products in Latin America, including innovative pharmaceuticals, biosimilars and complex generics. With more than 40 years of progressive healthcare experience and presence in more than 30 countries in Latin America and the Caribbean, SteinCares serves as a bridge between the world’s pharmaceutical companies and the region’s healthcare providers.
The company is highly committed to creating healthcare opportunities that positively impact the lives of patients and their families in Latin America, as has the vision to give more access to innovative and cost-effective healthcare to patients in the region.
For more information, please visit www.steincares.com